-+ 0.00%
-+ 0.00%
-+ 0.00%

Summit Therapeutics shareholders approve 8 million-share increase to 2020 stock incentive plan

PUBT·06/12/2026 20:12:32
Listen to the news
Summit Therapeutics shareholders approve 8 million-share increase to 2020 stock incentive plan
  • Summit Therapeutics held its annual stockholders meeting on June 10, 2026.
  • Shareholders ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Shareholders adopted an amendment to the 2020 Stock Incentive Plan, increasing shares issuable under the plan by 8,000,000.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Summit Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001599298-26-000054), on June 12, 2026, and is solely responsible for the information contained therein.